Product Program year 2021 Source: CMS Open Payments

Octrode SCS Leads

Device Neuromodulation

PDI 05414734406130

Open in the dashboard

General payments

$125,924

6,267 payments

Research payments

$0

0 payments

Through program year 2021, $125,924 in general payments and $0 in research payments were reported against Octrode SCS Leads (Neuromodulation).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $125,924 6,267

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $125,924 6,267 payments
Top recipients General payments · program year 2021
  1. Hisham Khan Pain Medicine · San Marcos, TX $3,733 3% · 98 payments
  2. Matthew McCarty Pain Medicine · Austin, TX $3,497 3% · 98 payments
  3. Kristian Delgado Interventional Pain Medicine · Killeen, TX $2,563 2% · 148 payments
  4. Angus Lowry Interventional Pain Medicine · Amarillo, TX $2,205 2% · 59 payments
  5. Alan Silberberg Interventional Pain Medicine · Kyle, TX $1,958 2% · 92 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Interventional Pain Medicine Pain Medicine $35,855 28% · 179 practitioners
  2. Pain Medicine Anesthesiology $27,678 22% · 165 practitioners
  3. Anesthesiology $9,025 7% · 77 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $7,867 6% · 97 practitioners
  5. Physician Assistant $7,286 6% · 117 practitioners

The top 5 of 63 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Texas $48,941 39% · 220 recipients
  2. Arizona $11,496 9% · 198 recipients
  3. Pennsylvania $7,376 6% · 122 recipients
  4. Florida $6,080 5% · 51 recipients
  5. California $5,537 4% · 70 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

6,267 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record